Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs Benitec Biopharma
Over the past year ARCT returned +2.6% and BNTC returned −47.0%; their daily moves had a correlation of 0.36.
ARCT +2.6% BNTC −47.0%Growth of $1, one year, split-adjusted
| Metric | ARCT | BNTC |
|---|---|---|
| Price | $9.54 | $8.40 |
| Market cap | $271.2M | $293.1M |
| Today | +0.53% | −1.06% |
| 1 month | −34.9% | −9.0% |
| 6 months | +13.4% | −31.1% |
| Year to date | +55.6% | −37.6% |
| 1 year | −4.3% | −48.7% |
| Revenue growth (YoY) | −89.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −803.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.2× | — |
| Net cash | $191.5M | $180.0M |
| Dividend yield | — | — |
| Volatility (60d) | 112.2% | 55.8% |
| Short % of float | 24.0% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).